GenSci

Changchun GeneScience Pharmaceutical Co., Ltd. (GenSci), established in 1997, is a subsidiary of Changchun High-Tech Industries (Group) Co., Ltd. (stock code 000661). As a pioneering genetic engineering pharmaceutical company, GenSci stands as Asia's largest manufacturing base for recombinant human growth hormone and the world's exclusive provider of a comprehensive range of recombinant growth hormone products. Driven by the vision of becoming a global leader in pediatric and women's health, GenSci focuses on improving the health and well-being of children and women by offering innovative solutions to address unmet medical needs. The company has expanded its product portfolio beyond its core strengths to include adult endocrinology, dermatology, rheumatology & immunology and oncology with a commitment to addressing more healthcare challenges in diverse therapeutic areas. With nearly 30 years of unwavering dedication to the healthcare industry, GenSci has seamlessly integrated services, marketing, production, and R&D to serve patients worldwide.